Role of Ca 2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle

Cellular Signalling

Volumn 24, Issue 11, 2012, Pages 2118-2122

  Mirza, K A ^a   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Ca 2+ signalling; Cancer cachexia; PIF receptor; Proteolysis inducing factor (PIF)

Indexed keywords

ANGIOTENSIN II; CALCIUM ION; CELL SURFACE RECEPTOR; GLYCOPROTEIN; LIPOPOLYSACCHARIDE; PROTEOLYSIS INDUCING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 AMINOETHOXYDIPHENYLBORANE; 2 PYRROLIDONE DERIVATIVE; 2-AMINOETHOXYDIPHENYL BORATE; BORON DERIVATIVE; CALCIUM; CHELATING AGENT; ESTRANE DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHOLIPASE C; PROTEOGLYCAN; PROTEOLYSIS INDUCING PEPTIDE; PROTEOLYSIS-INDUCING PEPTIDE; ZINC;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; INTRACELLULAR SIGNALING; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SKELETAL MUSCLE; ANIMAL; ATROPHY; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

MURINAE;

ANGIOTENSIN II; ANIMALS; ATROPHY; BORON COMPOUNDS; CALCIUM; CELL LINE; CHELATING AGENTS; ESTRENES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LIPOPOLYSACCHARIDES; MICE; MUSCLE, SKELETAL; PROTEOGLYCANS; PYRROLIDINONES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TYPE C PHOSPHOLIPASES; ZINC;

EID: 84865345055     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.07.016     Document Type: Article

References (29)

1. Tan B.H., Fearon K.C. Current Opinion in Clinical Nutrition and Metabolic Care 2008, 11:400-407.
2. Fearon K.C.H. The Proceedings of the Nutrition Society 1992, 51:251-265.
3. Tisdale M.J. Physiological Reviews 2009, 89:381-410.
4. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., Tisdale M. Nature 1996, 379:739-742.
5. Lorite M.J., Cariuk P., Tisdale M.J. British Journal of Cancer 1997, 76:1035-1040.
6. Eley H.L., Tisdale M.J. The Journal of Biological Chemistry 2007, 282:7087-7097.
7. Rowlands A.G., Panniers R., Henshaw E.C. The Journal of Biological Chemistry 1988, 263:5526-5533.
8. Wyke S.M., Tisdale M.J. British Journal of Cancer 2005, 92:711-721.
9. Song Y.-H., Li Y., Du J., Mitch W.E., Rosenthal N., Delafontaine P. The Journal of Clinical Investigation 2005, 115:451-458.
10. Todorov P.T., Wyke S.M., Tisdale M.J. Cancer Research 2007, 67:11419-11427.
11. Mirza K.A., Wyke S.M., Tisdale M.J. British Journal of Cancer 2011, 105:83-88.
12. Eley H.L., Russell S.T., Tisdale M.J. Cellular signalling 2010, 22:783-790.
13. Meacci E., Cencetti F., Formigli L., Squecco R., Donati C., Tiribilli B., Quercioli F., Zecchi Orlandini S., Francini F., Bruni P. The Biochemical Journal 2002, 362:349-357.
14. Sanders P.M., Russell S.T., Tisale M.J. British Journal of Cancer 2005, 93:425-434.
15. Eley H.L., Russell S.T., Tisdale M.J. American Journal of Physiology. Endocrinology and Metabolism 2008, 295:E1417-E1426.
16. Russell S.T., Tisdale M.J. Molecular and Cellular Biochemistry 2009, 330:171-179.
17. Felemez M., Speiss B. Journal of Inorganic Biochemistry 2001, 84:107-111.
18. Russell S.T., Siren P.M., Siren M.J., Tisdale M.J. Experimental Cell Research 2010, 316:286-295.
19. Hershfinkel M., Moran A., Grossman N., Sekler I. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:11749-11754.
20. Russell S.T., Rajani S., Dhadda R.S., Tisdale M.J. Experimental Cell Research 2009, 315:16-25.
21. Eley H.L., Russell S.T., Tisdale M.J. British Journal of Cancer 2007, 96:1216-1222.
22. Saelens X., Kailai M., Vandenabeele P. The Journal of Biological Chemistry 2001, 276:37670-37676.
23. Juin P., Pelletier M., Oliver L., Tremblais K., Gregoire M., Meflah K., Vallette F.M. The Journal of Biological Chemistry 1998, 273:17559-17564.
24. Fischer D.R., Sun X., Williams A.B., Gang G., Pritts T.A., James J.H., Molloy M., Fischer J.E., Paul R.J., Hasselgren P.O. Shock 2001, 15:200-207.
25. Sayeed M.M. Archives of Surgery 2000, 135:1432-1442.
26. Joffe M., Savage N., Isaacs H. The Biochemical Journal 1981, 196:663-667.
27. Smith H.J., Tisdale M.J. British Journal of Cancer 2003, 89:1783-1788.
28. Russell S.T., Siren P.M., Tisdale M.J. Cancer Chemotherapy and Pharmacology 2009, 64:517-527.
29. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., Hasselgren P.O., Frontera W.R., Lee J., Glass D.J., Shoelson S.E. Cell 2004, 119:285-298.